Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00545740 · ClinicalTrials.gov registry record · Phase 3
Prevention of Recurrence of Diverticulitis
A Phase 3 study, sponsored by Shire.
- Completed
- Registry status
- Phase 3
- Development phase
- 590
- Enrollment target
NCT00545740 is a Phase 3 study that has completed, run by Shire. The registered enrollment target is 590 participants.
The verdict
NCT00545740, a Phase 3 study, has completed, sponsored by Shire.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 590 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether SPD476 is effective in reducing recurrence of diverticulitis.
Interventions
- DRUG Placebo
- DRUG SPD476 (1.2g)
- DRUG SPD476 (2.4 g)
- DRUG SPD476 (4.8 g)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 590 participants |
| Start Date | 2007-11-28 |
| Est. Completion | 2012-03-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00545740
The ClinicalTrials.gov registry entry for NCT00545740 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 590 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shire, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT00545740 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00545740 about?
NCT00545740 is a clinical study titled "Prevention of Recurrence of Diverticulitis". The purpose of this study is to determine whether SPD476 is effective in reducing recurrence of diverticulitis.
What is the current status of trial NCT00545740?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 590 participants. The study started on 2007-11-28. Estimated completion is 2012-03-05.
What interventions are being tested in trial NCT00545740?
The interventions under investigation include: Placebo (DRUG), SPD476 (1.2g) (DRUG), SPD476 (2.4 g) (DRUG), SPD476 (4.8 g) (DRUG).
Who is sponsoring clinical trial NCT00545740?
This trial is sponsored by Shire, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.